Webb18 mars 2024 · It is currently -81.92% from its 52-week high and 16.53% from its 52-week low. How much is Immunitybio stock worth today? ( NASDAQ: IBRX) Immunitybio currently has 435,835,583 outstanding shares. With Immunitybio stock trading at $1.41 per share, the total value of Immunitybio stock (market capitalization) is $614.53M. Webb12 apr. 2024 · The price of IBRX fallen by 6.94% over the last 30 days. And in the last five days, it has fallen by -13.97%. Currently, the stock price of ImmunityBio Inc. (IBRX) is $1.54. In the most recent trading session, the stock underwent a significant upswing, peaking at $1.67 after opening at $1.58.
IBRX Stock Forecast, Price & News (ImmunityBio) - MarketBeat
WebbIn anticipation of the licensing being approved, IBRX is pursuing a partnership with a large pharmaceutical company for the commercialization of N-803 and hopes to complete the transaction in the first half of this year, but it's not certain of finalizing a deal. As relates to SRNEQ, keep in mind that IBRX closed at $1.44 on April 3, 2024 (SRNE ... Webb7 apr. 2024 · Read about ImmunityBio Inc Ordinary Shares (IBRX:XNAS) stock and today's latest news and financial updates. bruchsal party
IBRX Stock Price ImmunityBio Inc. Stock Quote (U.S.: Nasdaq ...
WebbFox Breaking News operates as a division of Ivy Morning. Fox Breaking News identifies itself as -- and is widely known to be - the most trusted source for ne... WebbIBRX support price is $1.63 and resistance is $2.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBRX stock will trade within this expected range on the day. WebbIBRX : 4.97 (+0.61%) ImmunityBio To Present Data From Multiple Clinical Trials at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire - Thu Apr 28, 8:00AM CDT. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced today its abstracts were accepted for … bruchsal pcr test